Cataloging the Structural Variations in Human GeneticsMay 10, 2007
A major new effort to uncover the medium- and large-scale genetic differences between humans may soon reveal DNA sequences that contribute to a wide range of diseases, according to a paper by Howard Hughes Medical Institute investigator Evan Eichler and 17 colleagues published in the May 10, 2007, Nature. The undertaking will help researchers identify structural variations in DNA sequences, which Eichler says amount to as much as five to ten percent of the human genome.
Past studies of human genetic differences usually have focused on the individual "letters" or bases of a DNA sequence. But the genetic differences between humans amount to more than simple spelling errors. "Structural changes — insertions, duplications, deletions, and inversions of DNA — are extremely common in the human population," says Eichler. "In fact, more bases are involved in structural changes in the genome than are involved in single-base-pair changes."
In some cases, individual genes appear in multiple copies because of duplications of DNA segments. In other cases, segments of DNA appear in some people but not others, which means that the "reference" human genome produced by the Human Genome Project is incomplete. "We're finding new sequence in the human genome that is not in the reference sequence," Eichler says.
These structural changes can influence both disease susceptibility and the normal functioning and appearance of the body. Color-blindness, increased risk of prostate cancer, and susceptibility to some forms of cardiovascular disease result from deletions of particular genes or parts of genes. Extra copies of a gene known as CC3L1 reduce a person's susceptibility to HIV infection and progression to AIDS. Lower than normal quantities of other genes can lead to intestinal or kidney diseases.
Variation in the number of genes or in gene regulation caused by structural rearrangements may also contribute to more common diseases. "The million dollar question is what is the genetic basis of diseases like diabetes, hypertension, and high cholesterol levels?" says Eichler. " We know there is a genetic factor, but what is the role of single base pair changes versus structural changes?"
The project Eichler and his colleagues describe in their paper will help answer this question. Using DNA from 62 people who were studied as part of the International HapMap Project, they are creating bacterial "libraries" of DNA segments for each person. The ends of the segments are then sequenced to uncover evidence of structural variation. Whenever such evidence is found, the entire DNA segment is sequenced to catalog all of the genetic differences between the segment and the reference sequence.
The result, says Eichler, will be a tool that geneticists can use to associate structural variation with particular diseases. "It might be that if I have an extra copy of gene A, my threshold for disease X may be higher or lower." Geneticists will then be able to test, or genotype, large numbers of individuals who have a particular disease to look for structural variants that they have in common. If a given variant is contributing to a disease, it will occur at a higher frequency in people with the disease.
Knowing about structural variation in the human genome will also allow geneticists to analyze single-base-pair changes more effectively, according to Aravinda Chakravarti, a geneticist at The Johns Hopkins University School of Medicine who was not a coauthor of the paper. "We have to look at structural variants from a different perspective, because they are adding or subtracting something from the genome," Chakravarti says. By understanding the patterns of both structural variants and single-base-pair changes in the population, "we'll learn a lot." To use both kinds of information in tandem, Eichler and his colleagues plan to incorporate the structural information they gather into existing databases on single-base-pair changes.
The project, which is being funded by the National Human Genome Research Institute at the National Institutes of Health, is difficult and expensive, Eichler admits. "It's a lot of work, because it's essentially doing 62 additional human genome projects," he says. "Having been involved in the first one, I swore I would never do it again. But in this case we're looking at the coolest parts of the genome."
Howard Hughes Medical Institute
Related Human Genetics Current Events and Human Genetics News Articles
Grabbing a parasite by the tail: U-M team solves 'jumping gene' mystery
Deep within your DNA, a tiny parasite lurks, waiting to pounce from its perch and land in the middle of an unsuspecting healthy gene. If it succeeds, it can make you sick.
UA-led research: Prevention of macular degeneration possible
A University of Arizona-led study on age-related macular degeneration - the eye disease that gradually destroys the ability to read, drive, write and see close-up in 30 percent of older Americans - likely will lead to a way to delay or prevent the disease, researchers say.
MRI-based screening improves assignment of stroke patients to endovascular treatment
A Massachusetts General Hospital (MGH)-- developed system for determining which patients with severe strokes are most likely to benefit from catheter-based systems for blood clot removal led to a greater percentage of screened patients receiving treatment and to outcomes similar to recent studies that found significant treatment benefits.
Targeted treatment produces rapid shrinkage of recurrent, BRAF-mutant brain tumor
A team led by Massachusetts General Hospital (MGH) investigators has reported the first successful use of a targeted therapy drug to treat a patient with a debilitating, recurrent brain tumor.
MGH team broadens utility of more compact CRISPR-Cas9 by increasing its targeting range
A team of Massachusetts General Hospital (MGH) investigators has shown that a method they developed to improve the usefulness and precision of the most common form of the gene-editing tools CRISPR-Cas9 RNA-guided nucleases can be applied to Cas9 enzymes from other bacterial sources.
Tumor RNA in platelets may diagnose and classify cancer, identify treatment strategies
Analysis of tumor RNA carried in platelets - blood components best known for their role in clotting - may prove to be more useful than other "liquid biopsy" technologies for diagnosing cancer and determining its primary location and potential therapeutic approaches.
Massive screen of drug combinations may find treatment for resistant, BRAF-mutant melanoma
A team of Massachusetts General Hospital (MGH) investigators has discovered a new combination of drugs that may be effective against one of the deadliest cancers, malignant melanoma.
Study finds how Alzheimer's-associated protein tangles spread through the brain
Massachusetts General Hospital (MGH) investigators have discovered a mechanism behind the spread of neurofibrillary tangles - one of the two hallmarks of Alzheimer's disease - through the brains of affected individuals.
Four microRNAs identified as playing key roles in cholesterol, lipid metabolism
Four tiny segments of RNA appear to play critical roles in controlling cholesterol and triglyceride metabolism. In their report receiving advance online publication in Nature Medicine, a Massachusetts General Hospital (MGH)-based research team describes finding how these microRNAs could reduce the expression of proteins playing key roles in the generation of beneficial HDL cholesterol, the disposal of artery-clogging LDL cholesterol, control of triglyceride levels and other risk factors of cardiovascular disease.
Study finds medication errors, adverse drug events in 1 out of 2 surgeries studied
The first study to measure the incidence of medication errors and adverse drug events during the perioperative period - immediately before, during and right after a surgical procedure - has found that some sort of mistake or adverse event occurred in every second operation and in 5 percent of observed drug administrations.
More Human Genetics Current Events and Human Genetics News Articles